Saliva, as a medium for assessing adrenocortical function in humans, has many advantages and a few distinct disadvantages. Interpretation of measurements of saliva cortisol is complicated by the contamination of saliva by steroid-binding proteins from blood plasma, enzyme activity in the salivary gland that converts cortisol to cortisone, and the amplification in saliva of the episodic fluctuations in systemic cortisol concentrations. We describe a new measurement technology that rejects artifacts from contamination of saliva by plasma protein, provides for measurement of both cortisol and cortisone, and integrates episodic fluctuations in concentration over a period of hours. This oral diffusion sink technology may greatly enhance the reliable interpretation of corticosteroid concentrations measured in saliva. Not only is saliva much more convenient to collect than blood or urine, but also concentrations of the corticosteroid hormones in saliva generally reflect the concentration of the free fraction of corticosteroids in blood plasma (1,2). This is important because most endocrine effects are thought to be exerted by the free concentration, rather than by the much larger concentration reversibly bound to the corticosteroid-binding globulin in plasma, and because the free concentration is related in a distinctly nonlinear way to the total corticosteroid concentration (3). To the degree that corticosteroid concentrations in saliva mirror those of the free concentration in plasma, they provide more direct information about the availability of corticosteroids to tissue. The relation of saliva cortisol to free cortisol in plasma does not depend on the saliva flow rate (1,4,5), and the change in saliva concentrations with systemic changes is prompt (6). However, problems in the interpretation of corticosteroid concentrations in saliva exist, related to the following three factors: #{149} in practice, saliva is frequently contaminated to some extent with plasma proteins, including corticosteroid-binding globulin and its reversibly bound corticosteroids (1, 7); #{149} the salivary gland contains 113-hydroxysteroid dehydrogenase (EC 1.1.1.146), which converts most of the free cortisol in blood plasma to cortisone as the hormone passes through the gland (8-10) Saliva (30 mL) was collected from one subject between 1100 and 1200 h; at 1130 h, blood samples were drawn from the subject, with EDTA as anticoagulant. The plasma was separated without delay. We added 3H-F to both plasma (0.28 tCi/mL) and saliva (0.014 p.Ci/mL). The plasma was loaded into a dialysis bag (Spectrapor no. Figure 1 (inset) . The average concentrations of F encountered by devices in the variable conditions were (c) 9.0 nmol/L, (d) 11.1 nmol/L, and (e) 12.5 nmol/L. We analyzed data by plotting F uptake as a function of average F concentration and examining the colinearity of uptake in the constant and the pulsed conditions.
because the free concentration is related in a distinctly nonlinear way to the total corticosteroid concentration (3). To the degree that corticosteroid concentrations in saliva mirror those of the free concentration in plasma, they provide more direct information about the availability of corticosteroids to tissue. The relation of saliva cortisol to free cortisol in plasma does not depend on the saliva flow rate (1, 4, 5) , and the change in saliva concentrations with systemic changes is prompt (6) . However, problems in the interpretation of corticosteroid concentrations in saliva exist, related to the following three factors:
#{149} in practice, saliva is frequently contaminated to some extent with plasma proteins, including corticosteroid-binding globulin and its reversibly bound corticosteroids (1, 7); #{149} the salivary gland contains 113-hydroxysteroid dehydrogenase (EC 1.1.1.146), which converts most of the free cortisol in blood plasma to cortisone as the hormone passes through the gland (8-10);
#{149} the corticosteroid concentrations in saliva vary over time even more dramatically than the concentrations of total corticosteroids in blood plasma, both in the course of normal diurnal variation (11-14) and in response to stimulation (14) (15) (16) (17) (18) .
Consequently, when a relatively high value of saliva cortisol is observed, any combination of the following interpretations is possible:
#{149} there was some degree of blood plasma contamination of saliva; #{149} the subject had a deficiency of salivary conversion of cortisol to cortisone; #{149} the sample was, by chance, collected during or shortly after a transient secretion episode; or #{149} the subject actually experienced an increased availability of corticosteroid to tissue.
We sought technical solutions to these problems of interpretation to better exploit the inherent advantages of monitoring corticosteroids in saliva. We report here a method that allows unambiguous interpretation of corticosteroid values while retaining the advantages of saliva-based measurements.
Our method makes use of a device called an oral diffusion sink (ODS).1 As the name suggests, the ODS is installed in the mouth of a subject, where it accumulates by passive diffusion the compounds of interest to be measured.
The device is a small, sealed plastic cylinder with many tiny ports, or window-like openings, covered by a dialysis membrane. These ports define a limited pathway for diffusion of the corticosteroids.
The diffusion, of course, results in a net transfer of material only along a concentration gradient; the steeper the concentration gradient, the more rapid the transfer. A diffusion gradient is maintained between the inside of the ODS and its environment by containing inside the device a potent binder of the compounds of interest. Co., Downers Grove, IL) overnight. Tritium accumulation was measured with a Packard 2000CA liquid scintillation analyzer. The concentration of 3H-F in the incubation buffer was determined by counting the radioactivity in replicate 100-iL aliquots.
Influence of mass-flow properties of the medium on the uptake rate. We compared the rate of uptake of 3H-F from two media: a standard saliva-like buffer as described above, in which free mixing and convection could take place, and a gelled medium, in which diffusion was the only means of mass transport. Buffer S was heated to boiling and Bacto-agar (Difco Labs., Detroit, MI) was added, 5 gIL. We added F with a trace amount of 3H-F to the buffer S-agar during cooling. Buffer S without agar was similarly prepared. The final concentration ofF in each preparation was -28 nmol/L (higher because of evaporative losses in buffer 5-agar). The buffers were aliquoted into small polypropylene vials supported in a 37 #{176}C water bath. As the agar gelled, an ODS was added to each vial. The buffer S-agar completely gelled at 37 #{176}C. After a 2-h incubation, the devices were retrieved and rinsed, then placed in 4 mL of scintillation cocktail overnight. Saliva (30 mL) was collected from one subject between 1100 and 1200 h; at 1130 h, blood samples were drawn from the subject, with EDTA as anticoagulant. The plasma was separated without delay. We added 3H-F to both plasma (0.28 tCi/mL) and saliva (0.014 p.Ci/mL). Figure 1 (inset) . The average concentrations of F encountered by devices in the variable conditions were (c) 9.0 nmol/L, (d) 11.1 nmol/L, and (e) 12.5 nmol/L. We analyzed data by plotting F uptake as a function of average F concentration and examining the colinearity of uptake in the constant and the pulsed conditions.
Differences in uptake between treatments were also examined by analysis of variance (ANOVA). Correlation between corticosteroid concentrations of frequently collected saliva and ODS samples. In a separate protocol, three subjects installed ODS devices, and at the same time began collecting 2-mL saliva samples every 10 mm. After 2 h of simultaneous ODS integration and saliva sampling, the ODS devices were collected and the saliva samples frozen. Subjects repeated this procedure at different times of day and during various activities, including reading, laboratory work, and exercise.
Preliminary Studies with Human Subjects
Equal aliquots of saliva from the 12 samples, corresponding to each pair of ODS devices, were pooled after the saliva samples were thawed and centrifuged to pellet debris. The saliva pools were then differentially analyzed for B and F by an HPLC/ultraviolet procedure (21) different from that used for analyzing ODS devices. The corresponding ODS devices were analyzed as described above. We analyzed the agreement of estimates of mean saliva E and F by the two methods by using correlation analysis.
All statistical calculations were made with the NCSS sy8tem (Dr. J. L. Hintze, Kaysville, UT). by gelling the medium with agar had no effect on the rate of uptake of 3H-F by ODS devices. The amount of 3H-F taken up by devices in 2 h was equivalent to the 3H-F content of 75 mg (75 L) of medium. This corresponds to an uptake constant (as defined above) of 0.0375 mIJh; the relatively high value is attributable to the particular batch of devices we used in this experiment.
Results

In Vitro Studies
Blood plasma contained 28 times as much 3H-F per unit volume as saliva, against which it was extensively dialyzed at 20#{176}C. Addition of equilibrated plasma to saliva at 1% (see above) caused an increase of -35% in total 3H-F; plasma contamination of 5% more than doubled the total 3H-F content. However, as Table 1 shows, ODS performance was unaffected by containination of saliva by blood plasma.
The ODS responded accurately in representing the average hormone availability produced by a single brief and extreme pulse ofF in the environment, as well as by multiple pulses occurring in 2 h. As Figure 1 shows, 
Studies with Human Subjects
All five subjects completed the protocol and none reported any discomfort in using the ODS devices as instructed. Of the 30 potential observations, two from one subject and one from another subject were void due to negligent timing. All the missing observations were in the afternoon.
A two-way ANOVA on total corticosteroids (i.e., E + F) showed that there was significant variation among the five normal subjects [F(4,17) = 15.21, P <0.0001]. Figure 2 shows that subjects 1 and 5 differed from one another and from the remaining subjects. The variation in total corticosteroids from morning to afternoon was also highly significant [F(1,17) = 13.35, P <0.002]. The ANOVA term describing the interaction of subject with time of day did not reach significance, indicating that diurnal variation was similar across subjects. The ratio of F to E observed in each subject in the same study is shown in Figure 3 . Of five subjects, four showed F/B ratios of -0.2, whereas the remaining subject showed a significantly higher steroid in saliva was estimated independently by repeated saliva sampling and by ODS, we found the two measures highly correlated (r = 0.78, P <0.005). Figure  4 suggests that the estimate by ODS tended to be lower than that by saliva sampling. However, this trend did not approach statistical significance.
Discussion
The observed device-to-device precision is probably adequate for practically all investigations. All experiments reported here were conducted with devices selected without conscious bias from single manufacturing runs, and not individually calibrated.
The finding that gelling the buffer had no effect on the performance of ODS devices shows that the mass-flow properties of the medium are irrelevant to ODS performance. Diffusion of analyte through the gelled medium to the surface of an ODS port was as fast or faster than diffusion of the same material through the port into the ODS; if it had been slower, the lower analyte concentration just outside the membrane would have been reflected in a lower rate of accumulation of analyte by the device. Practically, therefore, such properties of the medium as viscosity and degree of convective mixing have no effect on ODS uptake performance. In addition, the absolute rate of accumulation of analyte by the ODS is slow: per minute, the amount of 3H-F accumulated was equivalent to the 3H-F content of only 0.62 L of medium, even though the particular devices in this experiment were at the upper limit of the observed distribution of uptake rates. In contrast, saliva in humans is secreted at a rate of 50 L/min, even during sleep, with much faster rates being common during the day (1). Apparently, therefore, the amount of analyte taken up by an ODS worn orally will not detectably deplete the analyte concentration of saliva.
The 
